Cargando…

Efficacy and safety of Dengyinnaotong Capsule in patients with Cognitive impairment caused by cerebral Small Vessel Disease: study protocol of a multicenter, randomized, open-label, controlled trial (De-CSVD trial)

BACKGROUND: Cerebral small vessel disease (CSVD) is a common syndrome in the older population, with a prevalence ranging from 5% in subjects aged 50 years to almost 100% in those aged 90 years and older. It is regarded to be a major cause of vascular cognitive impairment. Existing prevention and tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yan-Xia, Li, Jin-Cun, Tian, Min, Zheng, Mao-Yong, Zhang, Li-Ping, Zhang, Jin-Lu, Yu, Feng, Li, Yi-Zhao, Zhang, Qing-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386924/ https://www.ncbi.nlm.nih.gov/pubmed/35978350 http://dx.doi.org/10.1186/s13063-022-06646-6

Ejemplares similares

Cerebral Small Vessel Disease (CSVD) – Lessons From the Animal Models
por: Mustapha, Muzaimi, et al.
Publicado: (2019)

Acupuncture for patients with mild hypertension: study protocol of an open-label multicenter randomized controlled trial
por: Li, Juan, et al.
Publicado: (2013)

Efficacy and safety of polysaccharide iron complex capsules compared with iron sucrose in hemodialysis patients: study protocol for a randomized, open-label, positive control, multicenter trial (IHOPE)
por: Lu, Renhua, et al.
Publicado: (2021)

Brain Endothelial Cells Activate Neuroinflammatory Pathways in Response to Early Cerebral Small Vessel Disease (CSVD) Patients’ Plasma
por: Cifù, Adriana, et al.
Publicado: (2023)

The Relationship Between ADAMTS13 Activity and Overall Cerebral Small Vessel Disease Burden: A Cross-Sectional Study Based on CSVD
por: Sun, Wenbo, et al.
Publicado: (2021)

Efficacy and Safety of Mizoribine for the Treatment of Refractory Nephrotic Syndrome: Protocol for a Multicenter, Controlled, Open-label, Randomized Controlled Trial
por: Dong, Zheyi, et al.
Publicado: (2023)

Arteriolosclerosis CSVD: a common cause of dementia and stroke and its association with cognitive function and total MRI burden
por: Hua, Min, et al.
Publicado: (2023)

Significance of Haemodynamic and Haemostatic Factors in the Course of Different Manifestations of Cerebral Small Vessel Disease: The SHEF-CSVD Study—Study Rationale and Protocol
por: Staszewski, Jacek, et al.
Publicado: (2013)

Non breathing-related sleep fragmentation and imaging markers in patients with atherosclerotic cerebral small vessel disease (CSVD): a cross-sectional case-control study
por: Wang, Jihui, et al.
Publicado: (2020)

Guided meditation for vision acuity training on adolescent myopia: study protocol for an open-label, prospective, multicenter, randomized controlled trial
por: Li, Yibo, et al.
Publicado: (2022)

Comprehensive investigations of cerebral hemodynamic responses in CSVD patients with mental disorders: a pilot study
por: Wen, Dan, et al.
Publicado: (2023)

Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial
por: Terada-Hirashima, Junko, et al.
Publicado: (2020)

Angiotensin-converting enzyme inhibitor for post-transcatheter aortic valve implantation patients: study protocol for a multicenter randomized, open-label blinded endpoint control trial
por: Liao, Yan Biao, et al.
Publicado: (2021)

Sitafloxacin- Versus Moxifloxacin-Based Sequential Treatment for Mycoplasma Genitalium Infections: Protocol for a Multicenter, Open-Label Randomized Controlled Trial
por: Ando, Naokatsu, et al.
Publicado: (2023)

Remotely monitored transcranial direct current stimulation in pediatric cerebral palsy: open label trial protocol
por: Simpson, Emma A., et al.
Publicado: (2022)

PTPRZ1-METFUsion GENe (ZM-FUGEN) trial: study protocol for a multicentric, randomized, open-label phase II/III trial
por: Bao, Zhaoshi, et al.
Publicado: (2023)

ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial
por: Li, Qingguo, et al.
Publicado: (2019)

Remission effect of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus: a protocol for a multicenter, parallel-group, randomized, controlled, open-label trial
por: Yang, Xue, et al.
Publicado: (2023)

An Exploratory Trial of EPI-589 in Amyotrophic Lateral Sclerosis (EPIC-ALS): Protocol for a Multicenter, Open-Labeled, 24-Week, Single-Group Study
por: Haji, Shotaro, et al.
Publicado: (2023)

The effectiveness and safety of Tai Chi for patients with essential hypertension: study protocol for an open-label single-center randomized controlled trial
por: Li, Yuxi, et al.
Publicado: (2021)

The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1}
por: Xu, Mengzhuo, et al.
Publicado: (2023)

The cerebral mechanism of the specific and nonspecific effects of acupuncture based on knee osteoarthritis: study protocol for a randomized controlled trial
por: Zhang, Na, et al.
Publicado: (2020)

The Efficacy and Safety of Miconazole Nitrate Mucoadhesive Tablets versus Itraconazole Capsules in the Treatment of Oral Candidiasis: An Open-Label, Randomized, Multicenter Trial
por: Yan, Zhimin, et al.
Publicado: (2016)

The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial
por: Garcia-Manau, Pablo, et al.
Publicado: (2022)

Combination of first-line chemotherapy with Kanglaite injections versus first-line chemotherapy alone for advanced non-small-cell lung cancer: study protocol for an investigator-initiated, multicenter, open-label, randomized controlled trial
por: Gao, Ruike, et al.
Publicado: (2021)

Protocol: The Lacunar Intervention Trial 2 (LACI-2). A trial of two repurposed licenced drugs to prevent progression of cerebral small vessel disease
por: Wardlaw, Joanna, et al.
Publicado: (2020)

Correlation of blood pressure levels at different time periods throughout the day with total CSVD burden and MRI imaging markers
por: Yang, Hua, et al.
Publicado: (2023)

Correlations Between the Microstructural Changes of the Medial Temporal Cortex and Mild Cognitive Impairment in Patients With Cerebral Small Vascular Disease (cSVD): A Diffusion Kurtosis Imaging Study
por: Liu, Dongtao, et al.
Publicado: (2020)

Effects of Keluoxin capsule combined with losartan potassium on diabetic kidney disease: study protocol for a randomized double-blind placebo-controlled multicenter clinical trial
por: Wu, Rui, et al.
Publicado: (2020)

Comparison Between Pioglitazone/Metformin Combination Therapy and Sitagliptin/Metformin Combination Therapy on the Efficacy in Chinese Type 2 Diabetic Adults Insufficiently Controlled with Metformin: Study Protocol of an Open-Label, Multicenter, Non-Inferiority Parallel-Group Randomized Controlled Trial
por: Zhang, Fang, et al.
Publicado: (2021)

Efficacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial
por: Fang, Rui, et al.
Publicado: (2023)

MTHFR C677T polymorphism and cerebrovascular lesions in elderly patients with CSVD: A correlation analysis
por: Li, Zhuoran, et al.
Publicado: (2022)

Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial
por: Chen, Jie, et al.
Publicado: (2022)

Effects of immunoglobulin plus prednisolone in reducing coronary artery lesions in patients with Kawasaki disease: study protocol for a phase III multicenter, open-label, blinded-endpoints randomized controlled trial
por: Lin, Si-Yuan, et al.
Publicado: (2021)

Safety and Efficacy of Ranibizumab and Luseogliflozin Combination Therapy in Patients with Diabetic Macular Edema: Protocol for a Multicenter, Open-Label Randomized Controlled Trial
por: Ishibashi, Ryoichi, et al.
Publicado: (2020)

Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial
por: Turner, Nicholas A., et al.
Publicado: (2022)

Apatinib with etoposide capsules as a third- or further-line therapy for extensive-stage small cell lung cancer: an open-label, multicenter, single-arm phase II trial
por: He, Zhen, et al.
Publicado: (2021)

Efficacy and Safety of Lianhuaqingwen Capsules for the Prevention of Coronavirus Disease 2019: A Prospective Open-Label Controlled Trial
por: Gong, Xiaowei, et al.
Publicado: (2021)

Rationale and design of an investigator-initiated, multicenter, prospective open-label, randomized trial to evaluate the effect of ipragliflozin on endothelial dysfunction in type 2 diabetes and chronic kidney disease: the PROCEED trial
por: Tanaka, Atsushi, et al.
Publicado: (2020)

Multicenter study of lumen-apposing metal stents with or without pigtail in endoscopic ultrasound-guided biliary drainage for malignant obstruction—BAMPI TRIAL: an open-label, randomized controlled trial protocol
por: Garcia-Sumalla, Albert, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g4pu6dg2f3ddkr97a9vd6po3kc